EASTMAN KODAK ltEK TO SELL HOLDINGS
  Eastman Kodak Co said it plans
  to sell its 23 pct holding in ICN Pharmaceuticals ltICN and
  part of its nine pct holdings in Viratek ltVIRA
      It said the purpose of the investments had been to lay the
  groundwork for the creation of its Nucleic Acid Research
  Institute
      Since that has been achieved there is no longer any reason
  to maintain the equity positions Kodak said
      Kodak holds 470000 sahres of ICN currently trading at
  about 1834 and 700000 of Viratek trading at 44
  

